TLR7 and TLR8 as targets in cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1210913.pdf
Reference116 articles.
1. Ambach A, Bonnekoh B, Nguyen M, Schön MP, Gollnick H . (2004). Imiquimod, a toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro. Mol Immunol 40: 1307–1314.
2. Barland CO, Zettersten E, Brown BS, Ye J, Elias PM, Ghadially R . (2004). Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 122: 330–336.
3. Bath-Hextall F, Bong F, Perkins W, Williams H . (2004). Interventions for basal cell carcinoma of the skin: systematic review. Br Med J 329: 705.
4. Berman B, Sullivan TP, De Araujo T, Nadji T . (2003). Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol 149 (Suppl. 66): 59–61.
5. Bernstein DI, Harrison CJ, Tepe ER, Shahwan A, Miller RL . (1995). Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea pigs. Vaccine 13: 72–76.
Cited by 261 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study;PLOS ONE;2024-08-29
2. Imiquimod for the treatment of oral leukoplakia: A two‐center retrospective study;Oral Diseases;2024-07-15
3. Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID;International Journal of Molecular Sciences;2024-07-12
4. Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors;Bioactive Materials;2024-06
5. Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy;Coordination Chemistry Reviews;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3